17170-06-8Relevant academic research and scientific papers
Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands
Rogolino, Dominga,Cavazzoni, Andrea,Gatti, Anna,Tegoni, Matteo,Pelosi, Giorgio,Verdolino, Vincenzo,Fumarola, Claudia,Cretella, Daniele,Petronini, Pier Giorgio,Carcelli, Mauro
, p. 140 - 153 (2017)
The possibility to influence the physiological concentration of copper ions through the careful choice of ligands is emerging as a novel intriguing strategy in the treatment of pathologies such as cancer and Alzheimer. Thiosemicarbazones play an important
Copper(II) complexes of hybrid hydroxyquinoline-thiosemicarbazone ligands: GSK3β inhibition due to intracellular delivery of copper
Hickey, James L.,Crouch, Peter J.,Mey, Sithorn,Caragounis, Aphrodite,White, Jonathan M,White, Anthony R.,Donnelly, Paul S.
experimental part, p. 1338 - 1347 (2011/03/21)
Cognitive decline associated with Alzheimer's disease appears to be related to the hyper-phosphorylation of the protein tau as a consequence of increased activity of glycogen synthase kinase 3β (GSK3β), and subsequent formation of neurotoxic neurofibrillary tangles. Abberant metal ion homeostasis, particularly involving copper has been implicitly linked to the pathogenesis of the disease. Increasing intracellular copper concentrations has been found to trigger pathways that result in inhibition of GSK3β. The syntheses and characterisation of tetradentate hybrid hydroxyquinoline-thiosemicarbazone proligands is presented. The ligands form stable complexes with CuII where the copper ion is four coordinate and essentially square planar as characterised by single crystal X-ray crystallography. The reduction of the metal ion to CuI has been studied by electrochemical techniques and occurs at potentials that permit intracellular reduction. The new complexes show class dependent cell membrane permeability in neuronal-like SH-SY5Y cells with subsequent increases in intracellular copper concentrations. The increased intracellular copper results in a dose-dependent inhibition (phosphorylation) of GSK3β.
